[1] E. Philippou e E. Nikiphorou, «Are we really what we eat? Nutrition and its role in the onset of rheumatoid arthritis», Autoimmun. Rev., set. 2018.

[2] A. Coates, A. Hill, e S. Tan, «Nuts and Cardiovascular Disease Prevention», Curr. Atheroscler. Rep., vol. 20, n. 10, pag. 48, ott. 2018.

[3] C. Sánchez-González, C. J. Ciudad, V. Noé, e M. Izquierdo-Pulido, «Health benefits of walnut polyphenols: An exploration beyond their lipid profile», Crit. Rev. Food Sci. Nutr., vol. 57, n. 16, pagg. 3373–3383, nov. 2017.

[4] M. Hahn, M. Baierle, M. F. Charão, G. B. Bubols, F. S. Gravina, P. Zielinsky, M. D. Arbo, e S. Cristina Garcia, «Polyphenol-rich food general and on pregnancy effects: a review», Drug Chem. Toxicol., vol. 40, n. 3, pagg. 368–374, lug. 2017.

[5] A. Masci, S. Carradori, M. A. Casadei, P. Paolicelli, S. Petralito, R. Ragno, e S. Cesa, «Lycium barbarum polysaccharides: Extraction, purification, structural characterisation and evidence about hypoglycaemic and hypolipidaemic effects. A review», Food Chem., vol. 254, pagg. 377–389, lug. 2018.

[6] D. Qian, Y. Zhao, G. Yang, e L. Huang, «Systematic Review of Chemical Constituents in the Genus Lycium (Solanaceae)», Molecules, vol. 22, n. 6, pag. 911, giu. 2017.

[7] Y. Gao, Y. Wei, Y. Wang, F. Gao, e Z. Chen, «Lycium Barbarum: A Traditional Chinese Herb and A Promising Anti-Aging Agent», Aging Dis., vol. 8, n. 6, pag. 778, dic. 2017.

[8] E. Ros, «Nuts and novel biomarkers of cardiovascular disease», Am. J. Clin. Nutr., vol. 89, n. 5, pag. 1649S–1656S, mag. 2009.

[9] J. Mukuddem-Petersen, W. Oosthuizen, e J. C. Jerling, «A Systematic Review of the Effects of Nuts on Blood Lipid Profiles in Humans», J. Nutr., vol. 135, n. 9, pagg. 2082–2089, set. 2005.

[10] A. E. Griel e P. M. Kris-Etherton, «Tree nuts and the lipid profile: a review of clinical studies.», Br. J. Nutr., vol. 96 Suppl 2, pagg. S68-78, nov. 2006.

[11] M. Gorzynik-Debicka, P. Przychodzen, F. Cappello, A. Kuban-Jankowska, A. Marino Gammazza, N. Knap, M. Wozniak, e M. Gorska-Ponikowska, «Potential Health Benefits of Olive Oil and Plant Polyphenols», Int. J. Mol. Sci., vol. 19, n. 3, pag. 686, feb. 2018.

[12] M. Becatti e C. Fiorillo, «Hazelnut-enriched chocolate improves flow-mediated artery dilatation via inhibition of oxidative stress», Intern. Emerg. Med., set. 2018.

[13] C. Nocella, V. Cammisotto, L. Fianchini, A. D’Amico, M. Novo, V. Castellani, L. Stefanini, F. Violi, e R. Carnevale, «Extra Virgin Olive Oil and Cardiovascular Diseases: Benefits for Human Health», Endocrine, Metab. Immune Disord. - Drug Targets, vol. 18, n. 1, pagg. 4–13, dic. 2017.

[14] R. Casas, R. Estruch, e E. Sacanella, «The Protective Effects of Extra Virgin Olive Oil on Immune-mediated Inflammatory Responses», Endocrine, Metab. Immune Disord. - Drug Targets, vol. 18, n. 1, pagg. 23–35, dic. 2017.

[15] C. Cantini, P. Salusti, M. Romi, A. Francini, e L. Sebastiani, «Sensory profiling and consumer acceptability of new dark cocoa bars containing Tuscan autochthonous food products», Food Sci. Nutr., vol. 6, n. 2, pagg. 245–252, mar. 2018.

[16] S. Sanati, B. M. Razavi, e H. Hosseinzadeh, «A review of the effects of Capsicum annuum L. and its constituent, capsaicin, in metabolic syndrome.», Iran. J. Basic Med. Sci., vol. 21, n. 5, pagg. 439–448, mag. 2018.

[17] J. Zheng, S. Zheng, Q. Feng, Q. Zhang, e X. Xiao, «Dietary capsaicin and its anti-obesity potency: from mechanism to clinical implications», Biosci. Rep., vol. 37, n. 3, pag. BSR20170286, giu. 2017.

[18] A. Dairam, R. Fogel, S. Daya, e J. L. Limson, «Antioxidant and Iron-Binding Properties of Curcumin, Capsaicin, and S -Allylcysteine Reduce Oxidative Stress in Rat Brain Homogenate», J. Agric. Food Chem., vol. 56, n. 9, pagg. 3350–3356, mag. 2008.

[19] B. L. Richards, S. L. Whittle, e R. Buchbinder, «Neuromodulators for pain management in rheumatoid arthritis», Cochrane Database Syst. Rev., vol. 1, pag. CD008921, gen. 2012.

[20] U. Singh e J. A. Bernstein, «Intranasal capsaicin in management of nonallergic (vasomotor) rhinitis.», Prog. Drug Res., vol. 68, pagg. 147–70, 2014.

[21] Y.-P. Liu, F.-X. Dong, X. Chai, S. Zhu, B.-L. Zhang, e D.-S. Gao, «Role of Autophagy in Capsaicin-Induced Apoptosis in U251 Glioma Cells», Cell. Mol. Neurobiol., vol. 36, n. 5, pagg. 737–743, lug. 2016.

[22] L. ZHENG, J. CHEN, Z. MA, W. LIU, F. YANG, Z. YANG, K. WANG, X. WANG, D. HE, L. LI, e J. ZENG, «Capsaicin enhances anti-proliferation efficacy of pirarubicin via activating TRPV1 and inhibiting PCNA nuclear translocation in 5637 cells», Mol. Med. Rep., vol. 13, n. 1, pagg. 881–887, gen. 2016.

[23] G. Secchi, I nostri alimenti : caratteristiche merceologiche e nutritive dei prodotti alimentari. Hoepli, 1979.

[24] Y. Zhao e Z.-Y. Chen, «Roles of Spicy Foods and Their Bioactive Compounds in Management of Hypercholesterolemia», J. Agric. Food Chem., vol. 66, n. 33, pagg. 8662–8671, ago. 2018.

[25] M. Lu, Y. Cao, J. Xiao, M. Song, e C.-T. Ho, «Molecular mechanisms of the anti-obesity effect of bioactive ingredients in common spices: a review.», Food Funct., vol. 9, n. 9, pagg. 4569–4581, set. 2018.

[26] A. Jafarzadeh e M. Nemati, «Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties», J. Neuroimmunol., vol. 324, pagg. 54–75, nov. 2018.

[27] G. Ozgoli e M. Saei Ghare Naz, «Effects of complementary medicine on nausea and vomiting in pregnancy: A systematic review», Int. J. Prev. Med., vol. 9, n. 1, pag. 75, 2018.

[28] S. A. Banihani, «Ginger and Testosterone», Biomolecules, vol. 8, n. 4, pag. 119, ott. 2018.

[29] G. Nieto, G. Ros, e J. Castillo, «Antioxidant and Antimicrobial Properties of Rosemary (Rosmarinus officinalis, L.): A Review», Medicines, vol. 5, n. 3, pag. 98, set. 2018.

[30] M. Lu, Y. Cao, J. Xiao, M. Song, e C.-T. Ho, «Molecular mechanisms of the anti-obesity effect of bioactive ingredients in common spices: a review.», Food Funct., vol. 9, n. 9, pagg. 4569–4581, set. 2018.

[31] M. Naimi, F. Vlavcheski, H. Shamshoum, e E. Tsiani, «Rosemary Extract as a Potential Anti-Hyperglycemic Agent: Current Evidence and Future Perspectives», Nutrients, vol. 9, n. 9, pag. 968, set. 2017.

[32] F. V. Hassani, K. Shirani, e H. Hosseinzadeh, «Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review», Naunyn. Schmiedebergs. Arch. Pharmacol., vol. 389, n. 9, pagg. 931–949, set. 2016.

[33] J. Moore, M. Yousef, e E. Tsiani, «Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols», Nutrients, vol. 8, n. 11, pag. 731, nov. 2016.

[34] S. Habtemariam, «The Therapeutic Potential of Rosemary ( Rosmarinus officinalis ) Diterpenes for Alzheimer’s Disease», Evidence-Based Complement. Altern. Med., vol. 2016, pagg. 1–14, 2016.

[35] M. Hariri e R. Ghiasvand, «Cinnamon and Chronic Diseases», in Advances in experimental medicine and biology, vol. 929, 2016, pagg. 1–24.

[36] A. B. Medagama, «The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials», Nutr. J., vol. 14, n. 1, pag. 108, dic. 2015.

[37] R. B. Costello, J. T. Dwyer, L. Saldanha, R. L. Bailey, J. Merkel, e E. Wambogo, «Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review», J. Acad. Nutr. Diet., vol. 116, n. 11, pagg. 1794–1802, nov. 2016.